1,586 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Cozad Asset Management Inc.

Key Points

• Cozad Asset Management Inc. acquired a new position in Intuitive Surgical, purchasing 1,586 shares valued at approximately $785,000 in the first quarter.
• Insider selling activity was noted, with Myriam Curet selling 4,500 shares worth over $2.2 million, significantly reducing her ownership by 92.73%.
• Analysts have mixed ratings on Intuitive Surgical, with a consensus price target of $592.05 and reports of the company beating quarterly earnings expectations.

Cozad Asset Management Inc. purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,586 shares of the medical equipment provider's stock, valued at approximately $785,000.

A number of other institutional investors have also added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Intuitive Surgical by 54,010.7% in the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock valued at $14,999,630,000 after buying an additional 3,022,979 shares during the period. Capital Research Global Investors increased its holdings in Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after acquiring an additional 687,906 shares during the last quarter. Northern Trust Corp raised its stake in Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock valued at $1,889,126,000 after acquiring an additional 494,496 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $167,943,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Intuitive Surgical by 12.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,826,972 shares of the medical equipment provider's stock valued at $1,475,566,000 after purchasing an additional 319,694 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Intuitive Surgical Trading Up 0.4%

NASDAQ ISRG traded up $2.03 during trading hours on Friday, hitting $483.12. 2,982,876 shares of the company's stock traded hands, compared to its average volume of 1,997,437. The firm has a market capitalization of $173.19 billion, a P/E ratio of 67.38, a P/E/G ratio of 5.04 and a beta of 1.60. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The business's fifty day moving average price is $524.01 and its two-hundred day moving average price is $533.35.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business's revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.78 earnings per share. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ISRG shares. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a research report on Tuesday, July 8th. Truist Financial boosted their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a "buy" rating in a report on Wednesday, July 23rd. BTIG Research raised their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Royal Bank Of Canada boosted their price objective on Intuitive Surgical from $605.00 to $615.00 and gave the company an "outperform" rating in a research note on Wednesday, July 23rd. Finally, Piper Sandler restated an "overweight" rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $592.05.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the company's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total transaction of $121,631.76. Following the sale, the senior vice president owned 907 shares of the company's stock, valued at $510,740.77. This represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Gary S. Guthart sold 7,893 shares of the business's stock in a transaction dated Monday, July 28th. The stock was sold at an average price of $498.64, for a total transaction of $3,935,765.52. Following the completion of the sale, the insider owned 13,187 shares in the company, valued at approximately $6,575,565.68. This trade represents a 37.44% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,903 shares of company stock valued at $7,932,778. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.